Analyst Updates: Stocks to Watch This Week

This week's analyst activity includes price target adjustments for Portland General Electric, Neumora Therapeutics, Microchip Technology, ICON Public, and MongoDB.

Analyst Updates: Stocks to Watch This Week

Keep an eye on these stocks as Wall Street analysts weigh in with new ratings and price targets. This week's activity, reported by Benzinga, covers a range of industries, from utilities to pharmaceuticals to technology.

Portland General Electric (NYSE:POR)

Barclays has increased its price target for Portland General Electric (NYSE:POR) from $42.00 to $47.00. The firm maintains an "equal weight" rating on the stock. Other firms like UBS Group have also weighed in, reaffirming a neutral stance.

Power lines and pylons against a clear blue sky. The Portland General Electric logo is subtly overlaid on the image.

Neumora Therapeutics (NASDAQ:NMRA)

HC Wainwright has lowered its expectations for Neumora Therapeutics (NASDAQ:NMRA), reducing the target price from $30.00 to $18.00. Despite the price cut, the firm maintains a "buy" rating on the stock. Bank of America is among other analysts who have commented on Neumora Therapeutics.

Microchip Technology (NASDAQ:MCHP)

Microchip Technology (NASDAQ:MCHP) is seeing some positive movement. Needham & Company LLC raised its price objective from $60.00 to $66.00, maintaining a "buy" rating. Mizuho also increased its price target, from $58.00 to $68.00, with an "outperform" rating. However, Bank of America has downgraded Microchip Technology. This mixed sentiment makes MCHP an interesting stock to watch.

A close-up shot of a microchip with intricate circuitry visible. The Microchip Technology logo is subtly placed in the background.
"Analyst ratings can provide valuable insight, but investors should always conduct their own due diligence before making investment decisions."

ICON Public (NASDAQ:ICLR)

Robert W. Baird has reduced its target price for ICON Public (NASDAQ:ICLR) from $221.00 to $203.00. The firm maintains a "neutral" rating on the medical research company's stock.

MongoDB (NASDAQ:MDB)

A stylized representation of data flowing into a MongoDB database, depicted as a glowing sphere. The MongoDB logo is subtly included.

Rosenblatt Securities has reiterated its "buy" rating on shares of MongoDB (NASDAQ:MDB), with a target price of $350.00. Macquarie has also initiated coverage on MongoDB. MongoDB remains a popular pick among analysts.

These analyst updates provide a snapshot of current sentiment towards these companies. Keep in mind that these are just opinions, and the market can be unpredictable. Always do your own research before investing.

Share this article: